Dthera Sciences Overview

  • Year Founded
  • 2012

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 1

Employees

  • Latest Deal Type
  • M&A

Dthera Sciences General Information

Description

Developer of a digital therapeutic platform designed to deliver reminiscence therapy for people living with Alzheimer's disease and dementia. The company's EveryStory platform uses a secure, closed communication system to engage family members, enabling authorized users to share photos, record audio, and create personalized memories and stories to support quality of life and help reduce anxiety.

Contact Information

Website
www.dthera.com
Formerly Known As
Knowledge Machine International
Ownership Status
Acquired/Merged
Financing Status
Formerly Angel backed
Corporate Office
  • 7310 Miramar Road
  • Suite 350
  • San Diego, CA 92126
  • United States
+1 (858)
Primary Industry
Therapeutic Devices
Acquirer
Vertical(s)
Corporate Office
  • 7310 Miramar Road
  • Suite 350
  • San Diego, CA 92126
  • United States
+1 (858)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Dthera Sciences Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
6. Merger/Acquisition 11-May-2022 Completed Generating Revenue
5. PIPE 23-Jul-2018 Completed Generating Revenue
4. PIPE 19-Jul-2017 Completed Generating Revenue
3. PIPE 03-Jun-2016 Completed Generating Revenue
2. Angel (individual) 01-Jan-2015 Completed Generating Revenue
1. Reverse Merger 22-Oct-2014 Completed Generating Revenue
To view Dthera Sciences’s complete valuation and funding history, request access »

Dthera Sciences Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Dthera Sciences Former Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds
Songbird Development Corporation Minority
TCA Venture Group Angel Group Minority
To view Dthera Sciences’s complete investors history, request access »

Dthera Sciences Acquisitions (2)

Dthera Sciences’s most recent deal was a Merger/Acquisition with everyStory. The deal was made on 21-Sep-2016.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
everyStory 21-Sep-2016 Merger/Acquisition Systems and Information Management
Songbird Development 22-Oct-2014 Merger/Acquisition Household Appliances
To view Dthera Sciences’s complete acquisitions history, request access »

Dthera Sciences FAQs

  • When was Dthera Sciences founded?

    Dthera Sciences was founded in 2012.

  • Where is Dthera Sciences headquartered?

    Dthera Sciences is headquartered in San Diego, CA.

  • What is the size of Dthera Sciences?

    Dthera Sciences has 1 total employees.

  • What industry is Dthera Sciences in?

    Dthera Sciences’s primary industry is Therapeutic Devices.

  • Is Dthera Sciences a private or public company?

    Dthera Sciences is a Private company.

  • What is Dthera Sciences’s current revenue?

    The current revenue for Dthera Sciences is .

  • How much funding has Dthera Sciences raised over time?

    Dthera Sciences has raised $4.73M.

  • Who are Dthera Sciences’s investors?

    Songbird Development and TCA Venture Group have invested in Dthera Sciences.

  • When was Dthera Sciences acquired?

    Dthera Sciences was acquired on 11-May-2022.

  • Who acquired Dthera Sciences?

    Dthera Sciences was acquired by MoodSpark.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process